Immediate Impact
1 by Nobel laureates 2 from Science/Nature 50 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Electronic Skin for Health Monitoring Systems: Properties, Functions, and Applications
2024 Standout
Works of Els Everaert being referenced
LBA27 Erdafitinib (ERDA) or ERDA plus cetrelimab (CET) for patients with metastatic or locally advanced urothelial carcinoma (mUC) and Fibroblast Growth Factor Receptor alterations (FGFRa): First phase (Ph) II results from the NORSE study
2021
Bacteremia Due to Moraxella atlantae in a Cancer Patient
2002
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Els Everaert | 70 | 25 | 66 | 90 | 11 | 251 | |
| C. Jones | 45 | 54 | 105 | 40 | 15 | 256 | |
| Patricia Calleja | 46 | 40 | 66 | 24 | 16 | 300 | |
| Rune Sörnäs | 44 | 9 | 88 | 40 | 12 | 277 | |
| Jennifer Simpson | 26 | 49 | 40 | 61 | 18 | 252 | |
| Deborah A. Silverman | 35 | 70 | 77 | 37 | 10 | 268 | |
| Hyo Jin Han | 85 | 17 | 55 | 22 | 12 | 283 | |
| Barbara Galbardi | 12 | 27 | 52 | 37 | 17 | 247 | |
| Brayden March | 74 | 58 | 62 | 77 | 15 | 285 | |
| Frank J. Jeurissen | 16 | 57 | 102 | 133 | 11 | 225 | |
| Jinze Wu | 15 | 23 | 98 | 32 | 12 | 291 |
All Works
Login with ORCID to disown or claim papers
Loading papers...